Delta F508-CFTR channels: kinetics, activation by forskolin, and potentiation by xanthines.

Trafficking, activation, and kinetics of delta F508-cystic fibrosis transmembrane conductance regulator (CFTR) and CFTR were compared in stably transduced C127I mouse mammary epithelial cells. Western blots detected a small amount of fully glycosylated delta F508-CFTR Efflux of 125I was stimulated by forskolin with the same mean effective concentration (EC50; approximately 0.5 microM) for CFTR and delta F508-CFTR cells, but the maximum response was reduced more than fivefold and its latency increased approximately threefold in delta F508-CFTR cells. In delta F508-CFTR cells, 3-isobutyl-1-methylxanthine (IBMX; EC50 = 1.45 microM) and 8-cyclopentyl-1,3-dipropylxanthine (CPX; EC50 = 58 microM) increased the peak forskolin-stimulated efflux rate approximately 2.5-fold and decreased the time to peak. A sevenfold increase in intracellular adenosine 3',5'-cyclic monophosphate (cAMP) levels accompanied potentiation of forskolin-induced 125I efflux by IBMX but not by CPX. Elevation of intracellular cAMP increased linear voltage-independent whole cell currents 30-fold in CFTR and 4-fold in delta F508-CFTR cells; the response rate in delta F508-CFTR cells was much slower. Single-channel currents were detected in 57 of 68 cell-attached patches from forskolin-prestimulated CFTR cells vs. 6 of 35 patches in delta F508-CFTR cells. Mean number of active channels per patch was 4.1 for CFTR [open probability (Po) = 0.34] and 0.2 for delta F508-CFTR (Po = 0.11). The lower Po of delta F508-CFTR resulted from an approximately threefold longer mean interburst interval. We estimate that forskolin-stimulated chloride conductance of delta F508-CFTR C127I cells is < 5% of CFTR cells. CPX is approximately 25-fold more potent than IBMX in potentiating delta F508-CFTR and may operate by a mechanism other than elevation of cAMP.

[1]  R. Barthelson,et al.  Cyclic adenosine monophosphate-dependent kinase in cystic fibrosis tracheal epithelium. , 1987, The Journal of clinical investigation.

[2]  J. Beavo,et al.  Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. , 1990, Trends in pharmacological sciences.

[3]  M. Iannuzzi,et al.  A cystic fibrosis pancreatic adenocarcinoma cell line. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Matthew P. Anderson,et al.  Dysfunction of CFTR bearing the ΔF508 mutation , 1993, Journal of Cell Science.

[5]  K. Jacobson,et al.  A1 adenosine-receptor antagonists activate chloride efflux from cystic fibrosis cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[6]  N. Bradbury,et al.  DEFECTIVE β-ADRENERGIC SECRETORY RESPONSES IN SUBMANDIBULAR ACINAR CELLS FROM CYSTIC FIBROSIS PATIENTS , 1986, The Lancet.

[7]  D. Garbers,et al.  Inhibition of alkaline phosphatase by substituted xanthines. , 1979, Biochemical pharmacology.

[8]  J. Riordan,et al.  Mislocalization of ΔF508 CFTR in cystic fibrosis sweat gland , 1992, Nature Genetics.

[9]  J. Marshall,et al.  Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis , 1990, Cell.

[10]  T. Flotte,et al.  Defective regulation of outwardly rectifying Cl− channels by protein kinase A corrected by insertion of CFTR , 1992, Nature.

[11]  J. Hartman,et al.  Cystic fibrosis transmembrane conductance regulator mutations that disrupt nucleotide binding. , 1994, The Journal of clinical investigation.

[12]  Pascal Barbry,et al.  Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation , 1991, Nature.

[13]  R. Boucher,et al.  CFTR and outward rectifying chloride channels are distinct proteins with a regulatory relationship , 1993, Nature.

[14]  Matthew P. Anderson,et al.  Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells , 1990, Nature.

[15]  R. Frizzell,et al.  Separate Cl- conductances activated by cAMP and Ca2+ in Cl(-)-secreting epithelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Michael J. Hartshorn,et al.  Structural model of ATP-binding proteing associated with cystic fibrosis, multidrug resistance and bacterial transport , 1990, Nature.

[17]  K. Klinger,et al.  Expression and characterization of the cystic fibrosis transmembrane conductance regulator , 1990, Nature.

[18]  F. Collins,et al.  Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes. , 1991, Science.

[19]  M. Welsh,et al.  Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis , 1993, Cell.

[20]  F. Collins,et al.  Molecular basis of defective anion transport in L cells expressing recombinant forms of CFTR. , 1993, Human molecular genetics.

[21]  M. Knowles,et al.  Isobutylmethylxanthine fails to stimulate chloride secretion in cystic fibrosis airway epithelia. , 1993, American journal of respiratory cell and molecular biology.

[22]  W. Finkbeiner,et al.  Reverse transcription-polymerase chain reaction (RT-PCR) phenotypic analysis of cell cultures of human tracheal epithelium, tracheobronchial glands, and lung carcinomas. , 1993, American journal of respiratory cell and molecular biology.